nodes	percent_of_prediction	percent_of_DWPC	metapath
Nicardipine—CYP2C8—Spironolactone—dilated cardiomyopathy	0.104	0.409	CbGbCtD
Nicardipine—ABCB1—Lisinopril—dilated cardiomyopathy	0.0798	0.314	CbGbCtD
Nicardipine—ABCB1—Spironolactone—dilated cardiomyopathy	0.0703	0.277	CbGbCtD
Nicardipine—CACNA1D—sinoatrial node—dilated cardiomyopathy	0.0484	0.292	CbGeAlD
Nicardipine—CYP2C9—cardial valve—dilated cardiomyopathy	0.0228	0.138	CbGeAlD
Nicardipine—CALM1—sympathetic nervous system—dilated cardiomyopathy	0.0121	0.0733	CbGeAlD
Nicardipine—Felodipine—TNNC1—dilated cardiomyopathy	0.00691	0.481	CrCbGaD
Nicardipine—PDE1B—heart—dilated cardiomyopathy	0.00522	0.0315	CbGeAlD
Nicardipine—Cerebral ischaemia—Lisinopril—dilated cardiomyopathy	0.0052	0.031	CcSEcCtD
Nicardipine—CACNB2—cardiac ventricle—dilated cardiomyopathy	0.00491	0.0297	CbGeAlD
Nicardipine—Ear disorder—Lisinopril—dilated cardiomyopathy	0.00466	0.0277	CcSEcCtD
Nicardipine—CACNB2—myocardium—dilated cardiomyopathy	0.00462	0.0279	CbGeAlD
Nicardipine—CACNA2D1—cardiac ventricle—dilated cardiomyopathy	0.00461	0.0279	CbGeAlD
Nicardipine—PDE1A—heart—dilated cardiomyopathy	0.00437	0.0264	CbGeAlD
Nicardipine—CACNA2D1—myocardium—dilated cardiomyopathy	0.00434	0.0262	CbGeAlD
Nicardipine—Nimodipine—NR3C2—dilated cardiomyopathy	0.00421	0.293	CrCbGaD
Nicardipine—Injection site pain—Furosemide—dilated cardiomyopathy	0.0041	0.0244	CcSEcCtD
Nicardipine—CACNA1C—cardiac ventricle—dilated cardiomyopathy	0.00396	0.024	CbGeAlD
Nicardipine—Erectile dysfunction—Spironolactone—dilated cardiomyopathy	0.00356	0.0212	CcSEcCtD
Nicardipine—Throat sore—Lisinopril—dilated cardiomyopathy	0.00349	0.0208	CcSEcCtD
Nicardipine—Oropharyngeal discomfort—Lisinopril—dilated cardiomyopathy	0.00346	0.0206	CcSEcCtD
Nicardipine—CALM3—cardiac ventricle—dilated cardiomyopathy	0.00332	0.0201	CbGeAlD
Nicardipine—Felodipine—NR3C2—dilated cardiomyopathy	0.00325	0.226	CrCbGaD
Nicardipine—CACNB2—heart—dilated cardiomyopathy	0.00322	0.0195	CbGeAlD
Nicardipine—CALM3—myocardium—dilated cardiomyopathy	0.00312	0.0189	CbGeAlD
Nicardipine—Urine output increased—Furosemide—dilated cardiomyopathy	0.00303	0.018	CcSEcCtD
Nicardipine—CACNA2D1—heart—dilated cardiomyopathy	0.00303	0.0183	CbGeAlD
Nicardipine—Ventricular extrasystoles—Lisinopril—dilated cardiomyopathy	0.00278	0.0166	CcSEcCtD
Nicardipine—Polyuria—Furosemide—dilated cardiomyopathy	0.00277	0.0165	CcSEcCtD
Nicardipine—Oropharyngeal pain—Lisinopril—dilated cardiomyopathy	0.00276	0.0165	CcSEcCtD
Nicardipine—CACNB2—cardiac atrium—dilated cardiomyopathy	0.00276	0.0167	CbGeAlD
Nicardipine—CALM2—cardiac ventricle—dilated cardiomyopathy	0.00261	0.0158	CbGeAlD
Nicardipine—CACNA1C—heart—dilated cardiomyopathy	0.0026	0.0157	CbGeAlD
Nicardipine—CALM1—cardiac ventricle—dilated cardiomyopathy	0.00259	0.0157	CbGeAlD
Nicardipine—Neck pain—Lisinopril—dilated cardiomyopathy	0.00254	0.0152	CcSEcCtD
Nicardipine—Ventricular tachycardia—Lisinopril—dilated cardiomyopathy	0.00251	0.015	CcSEcCtD
Nicardipine—Ill-defined disorder—Spironolactone—dilated cardiomyopathy	0.0025	0.0149	CcSEcCtD
Nicardipine—CALM2—myocardium—dilated cardiomyopathy	0.00245	0.0148	CbGeAlD
Nicardipine—CALM1—myocardium—dilated cardiomyopathy	0.00244	0.0147	CbGeAlD
Nicardipine—Malaise—Spironolactone—dilated cardiomyopathy	0.00243	0.0145	CcSEcCtD
Nicardipine—CACNA1D—cardiac atrium—dilated cardiomyopathy	0.00241	0.0146	CbGeAlD
Nicardipine—Discomfort—Spironolactone—dilated cardiomyopathy	0.00226	0.0135	CcSEcCtD
Nicardipine—CACNA1C—cardiac atrium—dilated cardiomyopathy	0.00223	0.0134	CbGeAlD
Nicardipine—Orthostatic hypotension—Furosemide—dilated cardiomyopathy	0.00222	0.0132	CcSEcCtD
Nicardipine—Confusional state—Spironolactone—dilated cardiomyopathy	0.00222	0.0132	CcSEcCtD
Nicardipine—Hypokalaemia—Furosemide—dilated cardiomyopathy	0.00221	0.0132	CcSEcCtD
Nicardipine—Hypertonia—Lisinopril—dilated cardiomyopathy	0.0022	0.0131	CcSEcCtD
Nicardipine—CALM3—heart—dilated cardiomyopathy	0.00218	0.0132	CbGeAlD
Nicardipine—Thrombocytopenia—Spironolactone—dilated cardiomyopathy	0.00215	0.0128	CcSEcCtD
Nicardipine—CHRM2—heart—dilated cardiomyopathy	0.00215	0.013	CbGeAlD
Nicardipine—Somnolence—Spironolactone—dilated cardiomyopathy	0.00195	0.0116	CcSEcCtD
Nicardipine—Pollakiuria—Furosemide—dilated cardiomyopathy	0.00194	0.0116	CcSEcCtD
Nicardipine—Atrial fibrillation—Lisinopril—dilated cardiomyopathy	0.00193	0.0115	CcSEcCtD
Nicardipine—CALM3—cardiac atrium—dilated cardiomyopathy	0.00186	0.0113	CbGeAlD
Nicardipine—Feeling abnormal—Spironolactone—dilated cardiomyopathy	0.00181	0.0108	CcSEcCtD
Nicardipine—Sweating—Furosemide—dilated cardiomyopathy	0.0018	0.0107	CcSEcCtD
Nicardipine—Face oedema—Lisinopril—dilated cardiomyopathy	0.00176	0.0105	CcSEcCtD
Nicardipine—Body temperature increased—Spironolactone—dilated cardiomyopathy	0.00174	0.0103	CcSEcCtD
Nicardipine—CALM2—heart—dilated cardiomyopathy	0.00171	0.0103	CbGeAlD
Nicardipine—CALM1—heart—dilated cardiomyopathy	0.0017	0.0103	CbGeAlD
Nicardipine—Orthostatic hypotension—Lisinopril—dilated cardiomyopathy	0.00167	0.00993	CcSEcCtD
Nicardipine—Visual impairment—Furosemide—dilated cardiomyopathy	0.00162	0.00966	CcSEcCtD
Nicardipine—Hypersensitivity—Spironolactone—dilated cardiomyopathy	0.00162	0.00964	CcSEcCtD
Nicardipine—ADRA1A—heart—dilated cardiomyopathy	0.00161	0.0097	CbGeAlD
Nicardipine—Tinnitus—Furosemide—dilated cardiomyopathy	0.00157	0.00934	CcSEcCtD
Nicardipine—Angina pectoris—Lisinopril—dilated cardiomyopathy	0.00154	0.00915	CcSEcCtD
Nicardipine—Sweating increased—Lisinopril—dilated cardiomyopathy	0.00154	0.00915	CcSEcCtD
Nicardipine—Diarrhoea—Spironolactone—dilated cardiomyopathy	0.0015	0.00895	CcSEcCtD
Nicardipine—CALM2—cardiac atrium—dilated cardiomyopathy	0.00146	0.00885	CbGeAlD
Nicardipine—CALM1—cardiac atrium—dilated cardiomyopathy	0.00146	0.00881	CbGeAlD
Nicardipine—Dizziness—Spironolactone—dilated cardiomyopathy	0.00145	0.00865	CcSEcCtD
Nicardipine—Erectile dysfunction—Lisinopril—dilated cardiomyopathy	0.00145	0.00865	CcSEcCtD
Nicardipine—Vomiting—Spironolactone—dilated cardiomyopathy	0.0014	0.00832	CcSEcCtD
Nicardipine—Acute coronary syndrome—Lisinopril—dilated cardiomyopathy	0.00139	0.00826	CcSEcCtD
Nicardipine—Rash—Spironolactone—dilated cardiomyopathy	0.00139	0.00825	CcSEcCtD
Nicardipine—Dermatitis—Spironolactone—dilated cardiomyopathy	0.00138	0.00824	CcSEcCtD
Nicardipine—Vision blurred—Furosemide—dilated cardiomyopathy	0.00138	0.00822	CcSEcCtD
Nicardipine—Myocardial infarction—Lisinopril—dilated cardiomyopathy	0.00138	0.00821	CcSEcCtD
Nicardipine—Headache—Spironolactone—dilated cardiomyopathy	0.00138	0.0082	CcSEcCtD
Nicardipine—Sweating—Lisinopril—dilated cardiomyopathy	0.00135	0.00803	CcSEcCtD
Nicardipine—Agitation—Furosemide—dilated cardiomyopathy	0.00135	0.00802	CcSEcCtD
Nicardipine—Haematuria—Lisinopril—dilated cardiomyopathy	0.00134	0.00798	CcSEcCtD
Nicardipine—Sinusitis—Lisinopril—dilated cardiomyopathy	0.00132	0.00786	CcSEcCtD
Nicardipine—Vertigo—Furosemide—dilated cardiomyopathy	0.00132	0.00784	CcSEcCtD
Nicardipine—Nausea—Spironolactone—dilated cardiomyopathy	0.00131	0.00777	CcSEcCtD
Nicardipine—CYP2B6—heart—dilated cardiomyopathy	0.00127	0.00769	CbGeAlD
Nicardipine—Rhinitis—Lisinopril—dilated cardiomyopathy	0.00127	0.00754	CcSEcCtD
Nicardipine—CYP2C9—heart—dilated cardiomyopathy	0.00126	0.00761	CbGeAlD
Nicardipine—Oedema peripheral—Lisinopril—dilated cardiomyopathy	0.00124	0.00741	CcSEcCtD
Nicardipine—Dry mouth—Furosemide—dilated cardiomyopathy	0.00122	0.00726	CcSEcCtD
Nicardipine—Confusional state—Furosemide—dilated cardiomyopathy	0.00121	0.00718	CcSEcCtD
Nicardipine—Tinnitus—Lisinopril—dilated cardiomyopathy	0.00118	0.00701	CcSEcCtD
Nicardipine—Shock—Furosemide—dilated cardiomyopathy	0.00118	0.007	CcSEcCtD
Nicardipine—Flushing—Lisinopril—dilated cardiomyopathy	0.00117	0.00698	CcSEcCtD
Nicardipine—Thrombocytopenia—Furosemide—dilated cardiomyopathy	0.00117	0.00697	CcSEcCtD
Nicardipine—Hyperhidrosis—Furosemide—dilated cardiomyopathy	0.00116	0.00688	CcSEcCtD
Nicardipine—Hypotension—Furosemide—dilated cardiomyopathy	0.00112	0.00665	CcSEcCtD
Nicardipine—Tension—Lisinopril—dilated cardiomyopathy	0.00108	0.00642	CcSEcCtD
Nicardipine—Paraesthesia—Furosemide—dilated cardiomyopathy	0.00107	0.00639	CcSEcCtD
Nicardipine—Nervousness—Lisinopril—dilated cardiomyopathy	0.00107	0.00636	CcSEcCtD
Nicardipine—Somnolence—Furosemide—dilated cardiomyopathy	0.00106	0.00633	CcSEcCtD
Nicardipine—Vision blurred—Lisinopril—dilated cardiomyopathy	0.00104	0.00617	CcSEcCtD
Nicardipine—Tremor—Lisinopril—dilated cardiomyopathy	0.00103	0.00613	CcSEcCtD
Nicardipine—Pain—Furosemide—dilated cardiomyopathy	0.00102	0.00609	CcSEcCtD
Nicardipine—Constipation—Furosemide—dilated cardiomyopathy	0.00102	0.00609	CcSEcCtD
Nicardipine—Ill-defined disorder—Lisinopril—dilated cardiomyopathy	0.00102	0.00607	CcSEcCtD
Nicardipine—Malaise—Lisinopril—dilated cardiomyopathy	0.000991	0.0059	CcSEcCtD
Nicardipine—Vertigo—Lisinopril—dilated cardiomyopathy	0.000987	0.00588	CcSEcCtD
Nicardipine—Syncope—Lisinopril—dilated cardiomyopathy	0.000986	0.00587	CcSEcCtD
Nicardipine—Feeling abnormal—Furosemide—dilated cardiomyopathy	0.000985	0.00587	CcSEcCtD
Nicardipine—Gastrointestinal pain—Furosemide—dilated cardiomyopathy	0.000978	0.00582	CcSEcCtD
Nicardipine—Palpitations—Lisinopril—dilated cardiomyopathy	0.000971	0.00578	CcSEcCtD
Nicardipine—Loss of consciousness—Lisinopril—dilated cardiomyopathy	0.000966	0.00575	CcSEcCtD
Nicardipine—Body temperature increased—Furosemide—dilated cardiomyopathy	0.000945	0.00563	CcSEcCtD
Nicardipine—Abdominal pain—Furosemide—dilated cardiomyopathy	0.000945	0.00563	CcSEcCtD
Nicardipine—Arthralgia—Lisinopril—dilated cardiomyopathy	0.000936	0.00557	CcSEcCtD
Nicardipine—Chest pain—Lisinopril—dilated cardiomyopathy	0.000936	0.00557	CcSEcCtD
Nicardipine—Myalgia—Lisinopril—dilated cardiomyopathy	0.000936	0.00557	CcSEcCtD
Nicardipine—Anxiety—Lisinopril—dilated cardiomyopathy	0.000932	0.00555	CcSEcCtD
Nicardipine—Discomfort—Lisinopril—dilated cardiomyopathy	0.000925	0.0055	CcSEcCtD
Nicardipine—Dry mouth—Lisinopril—dilated cardiomyopathy	0.000915	0.00545	CcSEcCtD
Nicardipine—Confusional state—Lisinopril—dilated cardiomyopathy	0.000904	0.00539	CcSEcCtD
Nicardipine—Oedema—Lisinopril—dilated cardiomyopathy	0.000897	0.00534	CcSEcCtD
Nicardipine—Infection—Lisinopril—dilated cardiomyopathy	0.000891	0.00531	CcSEcCtD
Nicardipine—Shock—Lisinopril—dilated cardiomyopathy	0.000883	0.00525	CcSEcCtD
Nicardipine—Hypersensitivity—Furosemide—dilated cardiomyopathy	0.000881	0.00524	CcSEcCtD
Nicardipine—Thrombocytopenia—Lisinopril—dilated cardiomyopathy	0.000878	0.00523	CcSEcCtD
Nicardipine—Tachycardia—Lisinopril—dilated cardiomyopathy	0.000875	0.00521	CcSEcCtD
Nicardipine—Hyperhidrosis—Lisinopril—dilated cardiomyopathy	0.000867	0.00516	CcSEcCtD
Nicardipine—Asthenia—Furosemide—dilated cardiomyopathy	0.000858	0.00511	CcSEcCtD
Nicardipine—Hypotension—Lisinopril—dilated cardiomyopathy	0.000838	0.00499	CcSEcCtD
Nicardipine—Diarrhoea—Furosemide—dilated cardiomyopathy	0.000818	0.00487	CcSEcCtD
Nicardipine—Musculoskeletal discomfort—Lisinopril—dilated cardiomyopathy	0.000817	0.00487	CcSEcCtD
Nicardipine—Insomnia—Lisinopril—dilated cardiomyopathy	0.000811	0.00483	CcSEcCtD
Nicardipine—Paraesthesia—Lisinopril—dilated cardiomyopathy	0.000805	0.0048	CcSEcCtD
Nicardipine—Dyspnoea—Lisinopril—dilated cardiomyopathy	0.0008	0.00476	CcSEcCtD
Nicardipine—Somnolence—Lisinopril—dilated cardiomyopathy	0.000797	0.00475	CcSEcCtD
Nicardipine—Dizziness—Furosemide—dilated cardiomyopathy	0.000791	0.00471	CcSEcCtD
Nicardipine—Dyspepsia—Lisinopril—dilated cardiomyopathy	0.00079	0.0047	CcSEcCtD
Nicardipine—Pain—Lisinopril—dilated cardiomyopathy	0.000767	0.00457	CcSEcCtD
Nicardipine—Constipation—Lisinopril—dilated cardiomyopathy	0.000767	0.00457	CcSEcCtD
Nicardipine—Vomiting—Furosemide—dilated cardiomyopathy	0.00076	0.00453	CcSEcCtD
Nicardipine—Rash—Furosemide—dilated cardiomyopathy	0.000754	0.00449	CcSEcCtD
Nicardipine—Dermatitis—Furosemide—dilated cardiomyopathy	0.000753	0.00448	CcSEcCtD
Nicardipine—Headache—Furosemide—dilated cardiomyopathy	0.000749	0.00446	CcSEcCtD
Nicardipine—Feeling abnormal—Lisinopril—dilated cardiomyopathy	0.000739	0.0044	CcSEcCtD
Nicardipine—Gastrointestinal pain—Lisinopril—dilated cardiomyopathy	0.000734	0.00437	CcSEcCtD
Nicardipine—Nausea—Furosemide—dilated cardiomyopathy	0.00071	0.00423	CcSEcCtD
Nicardipine—Body temperature increased—Lisinopril—dilated cardiomyopathy	0.000709	0.00422	CcSEcCtD
Nicardipine—Abdominal pain—Lisinopril—dilated cardiomyopathy	0.000709	0.00422	CcSEcCtD
Nicardipine—ABCB1—heart—dilated cardiomyopathy	0.00068	0.00411	CbGeAlD
Nicardipine—Hypersensitivity—Lisinopril—dilated cardiomyopathy	0.000661	0.00394	CcSEcCtD
Nicardipine—Asthenia—Lisinopril—dilated cardiomyopathy	0.000644	0.00383	CcSEcCtD
Nicardipine—Diarrhoea—Lisinopril—dilated cardiomyopathy	0.000614	0.00365	CcSEcCtD
Nicardipine—Dizziness—Lisinopril—dilated cardiomyopathy	0.000593	0.00353	CcSEcCtD
Nicardipine—Vomiting—Lisinopril—dilated cardiomyopathy	0.00057	0.0034	CcSEcCtD
Nicardipine—Rash—Lisinopril—dilated cardiomyopathy	0.000566	0.00337	CcSEcCtD
Nicardipine—Dermatitis—Lisinopril—dilated cardiomyopathy	0.000565	0.00336	CcSEcCtD
Nicardipine—Headache—Lisinopril—dilated cardiomyopathy	0.000562	0.00335	CcSEcCtD
Nicardipine—Nausea—Lisinopril—dilated cardiomyopathy	0.000533	0.00317	CcSEcCtD
Nicardipine—CHRM2—GPCR downstream signaling—RAC1—dilated cardiomyopathy	3.06e-05	7.69e-05	CbGpPWpGaD
Nicardipine—ADRA1A—GPCR downstream signaling—RAC1—dilated cardiomyopathy	3.05e-05	7.66e-05	CbGpPWpGaD
Nicardipine—CHRM5—Signaling Pathways—ADRB2—dilated cardiomyopathy	3.04e-05	7.64e-05	CbGpPWpGaD
Nicardipine—CALM3—Signaling by GPCR—ADRB2—dilated cardiomyopathy	3.03e-05	7.6e-05	CbGpPWpGaD
Nicardipine—ADRA1B—Signaling Pathways—CXCR3—dilated cardiomyopathy	3.03e-05	7.6e-05	CbGpPWpGaD
Nicardipine—ADRA1D—Signaling Pathways—AGTR1—dilated cardiomyopathy	3.02e-05	7.57e-05	CbGpPWpGaD
Nicardipine—ADRA1B—Signaling by GPCR—AGT—dilated cardiomyopathy	2.98e-05	7.49e-05	CbGpPWpGaD
Nicardipine—CHRM1—GPCR downstream signaling—AGT—dilated cardiomyopathy	2.96e-05	7.44e-05	CbGpPWpGaD
Nicardipine—CHRM3—GPCR downstream signaling—AGT—dilated cardiomyopathy	2.95e-05	7.42e-05	CbGpPWpGaD
Nicardipine—PDE1A—Signaling by GPCR—EGFR—dilated cardiomyopathy	2.95e-05	7.4e-05	CbGpPWpGaD
Nicardipine—CALM3—Signaling by NGF—EGFR—dilated cardiomyopathy	2.94e-05	7.38e-05	CbGpPWpGaD
Nicardipine—CHRM1—Signaling Pathways—CXCL2—dilated cardiomyopathy	2.94e-05	7.37e-05	CbGpPWpGaD
Nicardipine—CHRM1—Signaling Pathways—AGTR2—dilated cardiomyopathy	2.94e-05	7.37e-05	CbGpPWpGaD
Nicardipine—ADRA1B—Signaling Pathways—ADRB1—dilated cardiomyopathy	2.93e-05	7.36e-05	CbGpPWpGaD
Nicardipine—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—dilated cardiomyopathy	2.93e-05	7.36e-05	CbGpPWpGaD
Nicardipine—CALM2—Signaling by GPCR—ADRB2—dilated cardiomyopathy	2.93e-05	7.35e-05	CbGpPWpGaD
Nicardipine—CALM1—Signaling by GPCR—ADRB2—dilated cardiomyopathy	2.93e-05	7.35e-05	CbGpPWpGaD
Nicardipine—CHRM3—Signaling Pathways—CXCL2—dilated cardiomyopathy	2.93e-05	7.35e-05	CbGpPWpGaD
Nicardipine—CHRM3—Signaling Pathways—AGTR2—dilated cardiomyopathy	2.93e-05	7.35e-05	CbGpPWpGaD
Nicardipine—CHRM2—GPCR downstream signaling—AGT—dilated cardiomyopathy	2.93e-05	7.34e-05	CbGpPWpGaD
Nicardipine—ADRA1A—GPCR downstream signaling—AGT—dilated cardiomyopathy	2.92e-05	7.32e-05	CbGpPWpGaD
Nicardipine—CHRM2—Signaling Pathways—AGTR2—dilated cardiomyopathy	2.9e-05	7.28e-05	CbGpPWpGaD
Nicardipine—CHRM2—Signaling Pathways—CXCL2—dilated cardiomyopathy	2.9e-05	7.28e-05	CbGpPWpGaD
Nicardipine—ADRA1A—Signaling Pathways—AGTR2—dilated cardiomyopathy	2.89e-05	7.26e-05	CbGpPWpGaD
Nicardipine—ADRA1A—Signaling Pathways—CXCL2—dilated cardiomyopathy	2.89e-05	7.26e-05	CbGpPWpGaD
Nicardipine—CYP2C9—Metabolism of lipids and lipoproteins—GPX1—dilated cardiomyopathy	2.88e-05	7.22e-05	CbGpPWpGaD
Nicardipine—ADRA1D—Signaling Pathways—ADRB2—dilated cardiomyopathy	2.86e-05	7.18e-05	CbGpPWpGaD
Nicardipine—CALM2—Signaling by NGF—EGFR—dilated cardiomyopathy	2.84e-05	7.14e-05	CbGpPWpGaD
Nicardipine—CALM1—Signaling by NGF—EGFR—dilated cardiomyopathy	2.84e-05	7.14e-05	CbGpPWpGaD
Nicardipine—CHRM1—Signaling by GPCR—RAC1—dilated cardiomyopathy	2.82e-05	7.07e-05	CbGpPWpGaD
Nicardipine—CHRM3—Signaling by GPCR—RAC1—dilated cardiomyopathy	2.81e-05	7.05e-05	CbGpPWpGaD
Nicardipine—CYP2C9—Metabolism of lipids and lipoproteins—CD36—dilated cardiomyopathy	2.8e-05	7.03e-05	CbGpPWpGaD
Nicardipine—CHRM2—Signaling by GPCR—RAC1—dilated cardiomyopathy	2.78e-05	6.98e-05	CbGpPWpGaD
Nicardipine—ADRA1A—Signaling by GPCR—RAC1—dilated cardiomyopathy	2.77e-05	6.96e-05	CbGpPWpGaD
Nicardipine—CHRM4—Signaling by GPCR—RAF1—dilated cardiomyopathy	2.77e-05	6.95e-05	CbGpPWpGaD
Nicardipine—CYP2C19—Metabolism of lipids and lipoproteins—AGT—dilated cardiomyopathy	2.77e-05	6.94e-05	CbGpPWpGaD
Nicardipine—CALM3—Signaling Pathways—PSEN2—dilated cardiomyopathy	2.76e-05	6.93e-05	CbGpPWpGaD
Nicardipine—CHRM4—Signaling Pathways—RPS6KB1—dilated cardiomyopathy	2.73e-05	6.86e-05	CbGpPWpGaD
Nicardipine—CHRM1—Signaling Pathways—CXCR3—dilated cardiomyopathy	2.73e-05	6.86e-05	CbGpPWpGaD
Nicardipine—CHRM3—Signaling Pathways—CXCR3—dilated cardiomyopathy	2.72e-05	6.83e-05	CbGpPWpGaD
Nicardipine—CALM3—Hemostasis—RAF1—dilated cardiomyopathy	2.72e-05	6.82e-05	CbGpPWpGaD
Nicardipine—CHRM2—Signaling Pathways—CXCR3—dilated cardiomyopathy	2.7e-05	6.77e-05	CbGpPWpGaD
Nicardipine—PDE1B—Signaling by GPCR—EGFR—dilated cardiomyopathy	2.7e-05	6.77e-05	CbGpPWpGaD
Nicardipine—PDE1A—Immune System—EGFR—dilated cardiomyopathy	2.69e-05	6.76e-05	CbGpPWpGaD
Nicardipine—CHRM1—Signaling by GPCR—AGT—dilated cardiomyopathy	2.69e-05	6.76e-05	CbGpPWpGaD
Nicardipine—ADRA1A—Signaling Pathways—CXCR3—dilated cardiomyopathy	2.69e-05	6.75e-05	CbGpPWpGaD
Nicardipine—CHRM3—Signaling by GPCR—AGT—dilated cardiomyopathy	2.68e-05	6.73e-05	CbGpPWpGaD
Nicardipine—CALM3—Immune System—ITGB1—dilated cardiomyopathy	2.67e-05	6.71e-05	CbGpPWpGaD
Nicardipine—CALM2—Signaling Pathways—PSEN2—dilated cardiomyopathy	2.67e-05	6.71e-05	CbGpPWpGaD
Nicardipine—CALM1—Signaling Pathways—PSEN2—dilated cardiomyopathy	2.67e-05	6.71e-05	CbGpPWpGaD
Nicardipine—CHRM2—Signaling by GPCR—AGT—dilated cardiomyopathy	2.66e-05	6.67e-05	CbGpPWpGaD
Nicardipine—CHRM5—Signaling by GPCR—RAF1—dilated cardiomyopathy	2.65e-05	6.66e-05	CbGpPWpGaD
Nicardipine—ADRA1A—Signaling by GPCR—AGT—dilated cardiomyopathy	2.65e-05	6.65e-05	CbGpPWpGaD
Nicardipine—CHRM1—Signaling Pathways—ADRB1—dilated cardiomyopathy	2.65e-05	6.64e-05	CbGpPWpGaD
Nicardipine—CHRM3—Signaling Pathways—ADRB1—dilated cardiomyopathy	2.64e-05	6.62e-05	CbGpPWpGaD
Nicardipine—CALM2—Hemostasis—RAF1—dilated cardiomyopathy	2.63e-05	6.6e-05	CbGpPWpGaD
Nicardipine—CALM1—Hemostasis—RAF1—dilated cardiomyopathy	2.63e-05	6.6e-05	CbGpPWpGaD
Nicardipine—CHRM5—Signaling Pathways—RPS6KB1—dilated cardiomyopathy	2.62e-05	6.57e-05	CbGpPWpGaD
Nicardipine—CHRM2—Signaling Pathways—ADRB1—dilated cardiomyopathy	2.61e-05	6.55e-05	CbGpPWpGaD
Nicardipine—ADRA1A—Signaling Pathways—ADRB1—dilated cardiomyopathy	2.6e-05	6.54e-05	CbGpPWpGaD
Nicardipine—CALM2—Immune System—ITGB1—dilated cardiomyopathy	2.58e-05	6.49e-05	CbGpPWpGaD
Nicardipine—CALM1—Immune System—ITGB1—dilated cardiomyopathy	2.58e-05	6.49e-05	CbGpPWpGaD
Nicardipine—PDE1A—Signaling Pathways—RAF1—dilated cardiomyopathy	2.54e-05	6.37e-05	CbGpPWpGaD
Nicardipine—CYP2C9—Metabolism of lipids and lipoproteins—AGT—dilated cardiomyopathy	2.52e-05	6.33e-05	CbGpPWpGaD
Nicardipine—ADRA1B—Signaling Pathways—AGTR1—dilated cardiomyopathy	2.5e-05	6.29e-05	CbGpPWpGaD
Nicardipine—ADRA1D—Signaling by GPCR—RAF1—dilated cardiomyopathy	2.49e-05	6.26e-05	CbGpPWpGaD
Nicardipine—PDE1A—Disease—EGFR—dilated cardiomyopathy	2.49e-05	6.24e-05	CbGpPWpGaD
Nicardipine—CHRM4—Signaling Pathways—RAC1—dilated cardiomyopathy	2.47e-05	6.19e-05	CbGpPWpGaD
Nicardipine—PDE1B—Immune System—EGFR—dilated cardiomyopathy	2.46e-05	6.18e-05	CbGpPWpGaD
Nicardipine—ADRA1D—Signaling Pathways—RPS6KB1—dilated cardiomyopathy	2.46e-05	6.17e-05	CbGpPWpGaD
Nicardipine—CALM3—Signaling Pathways—AGTR2—dilated cardiomyopathy	2.45e-05	6.15e-05	CbGpPWpGaD
Nicardipine—CALM3—Signaling Pathways—CXCL2—dilated cardiomyopathy	2.45e-05	6.15e-05	CbGpPWpGaD
Nicardipine—CALM3—Innate Immune System—RAF1—dilated cardiomyopathy	2.44e-05	6.14e-05	CbGpPWpGaD
Nicardipine—ADRA1B—Signaling Pathways—ADRB2—dilated cardiomyopathy	2.38e-05	5.96e-05	CbGpPWpGaD
Nicardipine—CALM1—Signaling Pathways—AGTR2—dilated cardiomyopathy	2.37e-05	5.95e-05	CbGpPWpGaD
Nicardipine—CALM2—Signaling Pathways—AGTR2—dilated cardiomyopathy	2.37e-05	5.95e-05	CbGpPWpGaD
Nicardipine—CALM2—Signaling Pathways—CXCL2—dilated cardiomyopathy	2.37e-05	5.95e-05	CbGpPWpGaD
Nicardipine—CALM1—Signaling Pathways—CXCL2—dilated cardiomyopathy	2.37e-05	5.95e-05	CbGpPWpGaD
Nicardipine—CALM2—Innate Immune System—RAF1—dilated cardiomyopathy	2.37e-05	5.94e-05	CbGpPWpGaD
Nicardipine—CALM1—Innate Immune System—RAF1—dilated cardiomyopathy	2.37e-05	5.94e-05	CbGpPWpGaD
Nicardipine—CHRM5—Signaling Pathways—RAC1—dilated cardiomyopathy	2.36e-05	5.93e-05	CbGpPWpGaD
Nicardipine—CHRM4—Signaling Pathways—AGT—dilated cardiomyopathy	2.36e-05	5.92e-05	CbGpPWpGaD
Nicardipine—CALM3—Signaling by GPCR—RAC1—dilated cardiomyopathy	2.35e-05	5.9e-05	CbGpPWpGaD
Nicardipine—CALM3—Adaptive Immune System—RAF1—dilated cardiomyopathy	2.35e-05	5.89e-05	CbGpPWpGaD
Nicardipine—PDE1B—Signaling Pathways—RAF1—dilated cardiomyopathy	2.32e-05	5.83e-05	CbGpPWpGaD
Nicardipine—CALM3—Signaling Pathways—CXCR3—dilated cardiomyopathy	2.28e-05	5.72e-05	CbGpPWpGaD
Nicardipine—CALM3—Immune System—CD36—dilated cardiomyopathy	2.28e-05	5.72e-05	CbGpPWpGaD
Nicardipine—PDE1B—Disease—EGFR—dilated cardiomyopathy	2.27e-05	5.71e-05	CbGpPWpGaD
Nicardipine—CALM1—Signaling by GPCR—RAC1—dilated cardiomyopathy	2.27e-05	5.71e-05	CbGpPWpGaD
Nicardipine—CALM2—Signaling by GPCR—RAC1—dilated cardiomyopathy	2.27e-05	5.71e-05	CbGpPWpGaD
Nicardipine—CALM2—Adaptive Immune System—RAF1—dilated cardiomyopathy	2.27e-05	5.7e-05	CbGpPWpGaD
Nicardipine—CALM1—Adaptive Immune System—RAF1—dilated cardiomyopathy	2.27e-05	5.7e-05	CbGpPWpGaD
Nicardipine—CHRM1—Signaling Pathways—AGTR1—dilated cardiomyopathy	2.26e-05	5.67e-05	CbGpPWpGaD
Nicardipine—CHRM5—Signaling Pathways—AGT—dilated cardiomyopathy	2.26e-05	5.67e-05	CbGpPWpGaD
Nicardipine—CHRM3—Signaling Pathways—AGTR1—dilated cardiomyopathy	2.25e-05	5.65e-05	CbGpPWpGaD
Nicardipine—CALM3—Signaling by GPCR—AGT—dilated cardiomyopathy	2.25e-05	5.64e-05	CbGpPWpGaD
Nicardipine—CHRM2—Signaling Pathways—AGTR1—dilated cardiomyopathy	2.23e-05	5.6e-05	CbGpPWpGaD
Nicardipine—ADRA1A—Signaling Pathways—AGTR1—dilated cardiomyopathy	2.22e-05	5.58e-05	CbGpPWpGaD
Nicardipine—ADRA1D—Signaling Pathways—RAC1—dilated cardiomyopathy	2.22e-05	5.58e-05	CbGpPWpGaD
Nicardipine—CALM3—Signaling Pathways—ADRB1—dilated cardiomyopathy	2.21e-05	5.54e-05	CbGpPWpGaD
Nicardipine—CALM2—Signaling Pathways—CXCR3—dilated cardiomyopathy	2.2e-05	5.54e-05	CbGpPWpGaD
Nicardipine—CALM1—Signaling Pathways—CXCR3—dilated cardiomyopathy	2.2e-05	5.54e-05	CbGpPWpGaD
Nicardipine—CALM2—Immune System—CD36—dilated cardiomyopathy	2.2e-05	5.53e-05	CbGpPWpGaD
Nicardipine—CALM1—Immune System—CD36—dilated cardiomyopathy	2.2e-05	5.53e-05	CbGpPWpGaD
Nicardipine—CALM1—Signaling by GPCR—AGT—dilated cardiomyopathy	2.17e-05	5.45e-05	CbGpPWpGaD
Nicardipine—CALM2—Signaling by GPCR—AGT—dilated cardiomyopathy	2.17e-05	5.45e-05	CbGpPWpGaD
Nicardipine—CHRM3—Metabolism—GPX1—dilated cardiomyopathy	2.16e-05	5.43e-05	CbGpPWpGaD
Nicardipine—CALM3—Immune System—RAC1—dilated cardiomyopathy	2.15e-05	5.39e-05	CbGpPWpGaD
Nicardipine—CHRM1—Signaling Pathways—ADRB2—dilated cardiomyopathy	2.14e-05	5.38e-05	CbGpPWpGaD
Nicardipine—CHRM3—Signaling Pathways—ADRB2—dilated cardiomyopathy	2.14e-05	5.36e-05	CbGpPWpGaD
Nicardipine—CALM1—Signaling Pathways—ADRB1—dilated cardiomyopathy	2.14e-05	5.36e-05	CbGpPWpGaD
Nicardipine—CALM2—Signaling Pathways—ADRB1—dilated cardiomyopathy	2.14e-05	5.36e-05	CbGpPWpGaD
Nicardipine—ADRA1D—Signaling Pathways—AGT—dilated cardiomyopathy	2.12e-05	5.33e-05	CbGpPWpGaD
Nicardipine—CHRM2—Signaling Pathways—ADRB2—dilated cardiomyopathy	2.12e-05	5.31e-05	CbGpPWpGaD
Nicardipine—ADRA1A—Signaling Pathways—ADRB2—dilated cardiomyopathy	2.11e-05	5.3e-05	CbGpPWpGaD
Nicardipine—CHRM3—Metabolism—CD36—dilated cardiomyopathy	2.1e-05	5.28e-05	CbGpPWpGaD
Nicardipine—CALM1—Immune System—RAC1—dilated cardiomyopathy	2.08e-05	5.22e-05	CbGpPWpGaD
Nicardipine—CALM2—Immune System—RAC1—dilated cardiomyopathy	2.08e-05	5.22e-05	CbGpPWpGaD
Nicardipine—ADRA1B—Signaling by GPCR—RAF1—dilated cardiomyopathy	2.07e-05	5.2e-05	CbGpPWpGaD
Nicardipine—ADRA1B—Signaling Pathways—RPS6KB1—dilated cardiomyopathy	2.04e-05	5.12e-05	CbGpPWpGaD
Nicardipine—CALM3—Disease—RAC1—dilated cardiomyopathy	1.98e-05	4.98e-05	CbGpPWpGaD
Nicardipine—CALM1—Disease—RAC1—dilated cardiomyopathy	1.92e-05	4.82e-05	CbGpPWpGaD
Nicardipine—CALM2—Disease—RAC1—dilated cardiomyopathy	1.92e-05	4.82e-05	CbGpPWpGaD
Nicardipine—CHRM4—Signaling by GPCR—EGFR—dilated cardiomyopathy	1.9e-05	4.77e-05	CbGpPWpGaD
Nicardipine—CHRM3—Metabolism—AGT—dilated cardiomyopathy	1.9e-05	4.76e-05	CbGpPWpGaD
Nicardipine—CALM3—Signaling Pathways—AGTR1—dilated cardiomyopathy	1.89e-05	4.73e-05	CbGpPWpGaD
Nicardipine—CHRM1—Signaling by GPCR—RAF1—dilated cardiomyopathy	1.87e-05	4.69e-05	CbGpPWpGaD
Nicardipine—CHRM3—Signaling by GPCR—RAF1—dilated cardiomyopathy	1.86e-05	4.67e-05	CbGpPWpGaD
Nicardipine—CYP2B6—Metabolism—GPX1—dilated cardiomyopathy	1.86e-05	4.67e-05	CbGpPWpGaD
Nicardipine—ADRA1B—Signaling Pathways—RAC1—dilated cardiomyopathy	1.84e-05	4.63e-05	CbGpPWpGaD
Nicardipine—CHRM2—Signaling by GPCR—RAF1—dilated cardiomyopathy	1.84e-05	4.63e-05	CbGpPWpGaD
Nicardipine—CHRM1—Signaling Pathways—RPS6KB1—dilated cardiomyopathy	1.84e-05	4.62e-05	CbGpPWpGaD
Nicardipine—ADRA1A—Signaling by GPCR—RAF1—dilated cardiomyopathy	1.84e-05	4.62e-05	CbGpPWpGaD
Nicardipine—CHRM3—Signaling Pathways—RPS6KB1—dilated cardiomyopathy	1.84e-05	4.61e-05	CbGpPWpGaD
Nicardipine—CALM1—Signaling Pathways—AGTR1—dilated cardiomyopathy	1.82e-05	4.58e-05	CbGpPWpGaD
Nicardipine—CALM2—Signaling Pathways—AGTR1—dilated cardiomyopathy	1.82e-05	4.58e-05	CbGpPWpGaD
Nicardipine—CYP2E1—Metabolism—GPX1—dilated cardiomyopathy	1.82e-05	4.57e-05	CbGpPWpGaD
Nicardipine—CHRM5—Signaling by GPCR—EGFR—dilated cardiomyopathy	1.82e-05	4.57e-05	CbGpPWpGaD
Nicardipine—CHRM2—Signaling Pathways—RPS6KB1—dilated cardiomyopathy	1.82e-05	4.56e-05	CbGpPWpGaD
Nicardipine—CYP3A5—Metabolism—GPX1—dilated cardiomyopathy	1.82e-05	4.56e-05	CbGpPWpGaD
Nicardipine—ADRA1A—Signaling Pathways—RPS6KB1—dilated cardiomyopathy	1.81e-05	4.55e-05	CbGpPWpGaD
Nicardipine—CYP2B6—Metabolism—CD36—dilated cardiomyopathy	1.81e-05	4.55e-05	CbGpPWpGaD
Nicardipine—CALM3—Metabolism—GPX1—dilated cardiomyopathy	1.81e-05	4.54e-05	CbGpPWpGaD
Nicardipine—CALM3—Signaling Pathways—ADRB2—dilated cardiomyopathy	1.79e-05	4.49e-05	CbGpPWpGaD
Nicardipine—ABCB1—Transmembrane transport of small molecules—RAF1—dilated cardiomyopathy	1.78e-05	4.47e-05	CbGpPWpGaD
Nicardipine—CYP2E1—Metabolism—CD36—dilated cardiomyopathy	1.77e-05	4.45e-05	CbGpPWpGaD
Nicardipine—CYP3A5—Metabolism—CD36—dilated cardiomyopathy	1.77e-05	4.44e-05	CbGpPWpGaD
Nicardipine—CALM3—Metabolism—CD36—dilated cardiomyopathy	1.76e-05	4.42e-05	CbGpPWpGaD
Nicardipine—ADRA1B—Signaling Pathways—AGT—dilated cardiomyopathy	1.76e-05	4.42e-05	CbGpPWpGaD
Nicardipine—CALM1—Metabolism—GPX1—dilated cardiomyopathy	1.75e-05	4.39e-05	CbGpPWpGaD
Nicardipine—CALM2—Metabolism—GPX1—dilated cardiomyopathy	1.75e-05	4.39e-05	CbGpPWpGaD
Nicardipine—PDE1A—Signaling Pathways—EGFR—dilated cardiomyopathy	1.74e-05	4.37e-05	CbGpPWpGaD
Nicardipine—CALM2—Signaling Pathways—ADRB2—dilated cardiomyopathy	1.73e-05	4.34e-05	CbGpPWpGaD
Nicardipine—CALM1—Signaling Pathways—ADRB2—dilated cardiomyopathy	1.73e-05	4.34e-05	CbGpPWpGaD
Nicardipine—ADRA1D—Signaling by GPCR—EGFR—dilated cardiomyopathy	1.71e-05	4.29e-05	CbGpPWpGaD
Nicardipine—CALM2—Metabolism—CD36—dilated cardiomyopathy	1.7e-05	4.28e-05	CbGpPWpGaD
Nicardipine—CALM1—Metabolism—CD36—dilated cardiomyopathy	1.7e-05	4.28e-05	CbGpPWpGaD
Nicardipine—CALM3—Innate Immune System—EGFR—dilated cardiomyopathy	1.68e-05	4.21e-05	CbGpPWpGaD
Nicardipine—CHRM1—Signaling Pathways—RAC1—dilated cardiomyopathy	1.66e-05	4.18e-05	CbGpPWpGaD
Nicardipine—CHRM3—Signaling Pathways—RAC1—dilated cardiomyopathy	1.66e-05	4.16e-05	CbGpPWpGaD
Nicardipine—CHRM2—Signaling Pathways—RAC1—dilated cardiomyopathy	1.64e-05	4.12e-05	CbGpPWpGaD
Nicardipine—ADRA1A—Signaling Pathways—RAC1—dilated cardiomyopathy	1.64e-05	4.11e-05	CbGpPWpGaD
Nicardipine—CHRM4—Signaling Pathways—RAF1—dilated cardiomyopathy	1.64e-05	4.11e-05	CbGpPWpGaD
Nicardipine—CYP2B6—Metabolism—AGT—dilated cardiomyopathy	1.63e-05	4.09e-05	CbGpPWpGaD
Nicardipine—CALM1—Innate Immune System—EGFR—dilated cardiomyopathy	1.62e-05	4.07e-05	CbGpPWpGaD
Nicardipine—CALM2—Innate Immune System—EGFR—dilated cardiomyopathy	1.62e-05	4.07e-05	CbGpPWpGaD
Nicardipine—CALM3—Adaptive Immune System—EGFR—dilated cardiomyopathy	1.61e-05	4.04e-05	CbGpPWpGaD
Nicardipine—CYP2E1—Metabolism—AGT—dilated cardiomyopathy	1.6e-05	4.01e-05	CbGpPWpGaD
Nicardipine—CYP3A5—Metabolism—AGT—dilated cardiomyopathy	1.59e-05	4e-05	CbGpPWpGaD
Nicardipine—PDE1B—Signaling Pathways—EGFR—dilated cardiomyopathy	1.59e-05	4e-05	CbGpPWpGaD
Nicardipine—CHRM1—Signaling Pathways—AGT—dilated cardiomyopathy	1.59e-05	3.99e-05	CbGpPWpGaD
Nicardipine—CALM3—Metabolism—AGT—dilated cardiomyopathy	1.59e-05	3.98e-05	CbGpPWpGaD
Nicardipine—CHRM3—Signaling Pathways—AGT—dilated cardiomyopathy	1.58e-05	3.98e-05	CbGpPWpGaD
Nicardipine—CYP2C8—Metabolism—GPX1—dilated cardiomyopathy	1.57e-05	3.95e-05	CbGpPWpGaD
Nicardipine—CHRM2—Signaling Pathways—AGT—dilated cardiomyopathy	1.57e-05	3.94e-05	CbGpPWpGaD
Nicardipine—CHRM5—Signaling Pathways—RAF1—dilated cardiomyopathy	1.57e-05	3.93e-05	CbGpPWpGaD
Nicardipine—ADRA1A—Signaling Pathways—AGT—dilated cardiomyopathy	1.56e-05	3.93e-05	CbGpPWpGaD
Nicardipine—CALM3—Signaling by GPCR—RAF1—dilated cardiomyopathy	1.56e-05	3.91e-05	CbGpPWpGaD
Nicardipine—CALM2—Adaptive Immune System—EGFR—dilated cardiomyopathy	1.56e-05	3.91e-05	CbGpPWpGaD
Nicardipine—CALM1—Adaptive Immune System—EGFR—dilated cardiomyopathy	1.56e-05	3.91e-05	CbGpPWpGaD
Nicardipine—CALM3—Signaling Pathways—RPS6KB1—dilated cardiomyopathy	1.54e-05	3.86e-05	CbGpPWpGaD
Nicardipine—CALM2—Metabolism—AGT—dilated cardiomyopathy	1.53e-05	3.85e-05	CbGpPWpGaD
Nicardipine—CALM1—Metabolism—AGT—dilated cardiomyopathy	1.53e-05	3.85e-05	CbGpPWpGaD
Nicardipine—CYP2C8—Metabolism—CD36—dilated cardiomyopathy	1.53e-05	3.85e-05	CbGpPWpGaD
Nicardipine—CALM2—Signaling by GPCR—RAF1—dilated cardiomyopathy	1.51e-05	3.78e-05	CbGpPWpGaD
Nicardipine—CALM1—Signaling by GPCR—RAF1—dilated cardiomyopathy	1.51e-05	3.78e-05	CbGpPWpGaD
Nicardipine—CALM2—Signaling Pathways—RPS6KB1—dilated cardiomyopathy	1.49e-05	3.73e-05	CbGpPWpGaD
Nicardipine—CALM1—Signaling Pathways—RPS6KB1—dilated cardiomyopathy	1.49e-05	3.73e-05	CbGpPWpGaD
Nicardipine—ADRA1D—Signaling Pathways—RAF1—dilated cardiomyopathy	1.47e-05	3.7e-05	CbGpPWpGaD
Nicardipine—CALM3—Immune System—RAF1—dilated cardiomyopathy	1.42e-05	3.57e-05	CbGpPWpGaD
Nicardipine—ADRA1B—Signaling by GPCR—EGFR—dilated cardiomyopathy	1.42e-05	3.56e-05	CbGpPWpGaD
Nicardipine—CYP2C19—Metabolism—GPX1—dilated cardiomyopathy	1.4e-05	3.53e-05	CbGpPWpGaD
Nicardipine—CALM3—Signaling Pathways—RAC1—dilated cardiomyopathy	1.39e-05	3.49e-05	CbGpPWpGaD
Nicardipine—CYP2C8—Metabolism—AGT—dilated cardiomyopathy	1.38e-05	3.46e-05	CbGpPWpGaD
Nicardipine—CALM2—Immune System—RAF1—dilated cardiomyopathy	1.38e-05	3.46e-05	CbGpPWpGaD
Nicardipine—CALM1—Immune System—RAF1—dilated cardiomyopathy	1.38e-05	3.46e-05	CbGpPWpGaD
Nicardipine—ABCB1—Metabolism—GPX1—dilated cardiomyopathy	1.37e-05	3.44e-05	CbGpPWpGaD
Nicardipine—CYP2C19—Metabolism—CD36—dilated cardiomyopathy	1.37e-05	3.43e-05	CbGpPWpGaD
Nicardipine—CALM2—Signaling Pathways—RAC1—dilated cardiomyopathy	1.34e-05	3.37e-05	CbGpPWpGaD
Nicardipine—CALM1—Signaling Pathways—RAC1—dilated cardiomyopathy	1.34e-05	3.37e-05	CbGpPWpGaD
Nicardipine—ABCB1—Metabolism—CD36—dilated cardiomyopathy	1.34e-05	3.35e-05	CbGpPWpGaD
Nicardipine—CALM3—Signaling Pathways—AGT—dilated cardiomyopathy	1.33e-05	3.33e-05	CbGpPWpGaD
Nicardipine—CALM3—Disease—RAF1—dilated cardiomyopathy	1.31e-05	3.3e-05	CbGpPWpGaD
Nicardipine—CYP2D6—Metabolism—GPX1—dilated cardiomyopathy	1.29e-05	3.24e-05	CbGpPWpGaD
Nicardipine—CALM1—Signaling Pathways—AGT—dilated cardiomyopathy	1.28e-05	3.22e-05	CbGpPWpGaD
Nicardipine—CALM2—Signaling Pathways—AGT—dilated cardiomyopathy	1.28e-05	3.22e-05	CbGpPWpGaD
Nicardipine—CYP2C9—Metabolism—GPX1—dilated cardiomyopathy	1.28e-05	3.22e-05	CbGpPWpGaD
Nicardipine—CHRM1—Signaling by GPCR—EGFR—dilated cardiomyopathy	1.28e-05	3.21e-05	CbGpPWpGaD
Nicardipine—CHRM3—Signaling by GPCR—EGFR—dilated cardiomyopathy	1.28e-05	3.2e-05	CbGpPWpGaD
Nicardipine—CALM2—Disease—RAF1—dilated cardiomyopathy	1.27e-05	3.19e-05	CbGpPWpGaD
Nicardipine—CALM1—Disease—RAF1—dilated cardiomyopathy	1.27e-05	3.19e-05	CbGpPWpGaD
Nicardipine—CHRM2—Signaling by GPCR—EGFR—dilated cardiomyopathy	1.26e-05	3.17e-05	CbGpPWpGaD
Nicardipine—ADRA1A—Signaling by GPCR—EGFR—dilated cardiomyopathy	1.26e-05	3.16e-05	CbGpPWpGaD
Nicardipine—CYP2D6—Metabolism—CD36—dilated cardiomyopathy	1.26e-05	3.16e-05	CbGpPWpGaD
Nicardipine—CYP2C9—Metabolism—CD36—dilated cardiomyopathy	1.25e-05	3.13e-05	CbGpPWpGaD
Nicardipine—CYP2C19—Metabolism—AGT—dilated cardiomyopathy	1.23e-05	3.09e-05	CbGpPWpGaD
Nicardipine—ADRA1B—Signaling Pathways—RAF1—dilated cardiomyopathy	1.22e-05	3.07e-05	CbGpPWpGaD
Nicardipine—ABCB1—Metabolism—AGT—dilated cardiomyopathy	1.2e-05	3.02e-05	CbGpPWpGaD
Nicardipine—CYP2D6—Metabolism—AGT—dilated cardiomyopathy	1.13e-05	2.84e-05	CbGpPWpGaD
Nicardipine—CYP2C9—Metabolism—AGT—dilated cardiomyopathy	1.12e-05	2.82e-05	CbGpPWpGaD
Nicardipine—CHRM4—Signaling Pathways—EGFR—dilated cardiomyopathy	1.12e-05	2.82e-05	CbGpPWpGaD
Nicardipine—CHRM1—Signaling Pathways—RAF1—dilated cardiomyopathy	1.1e-05	2.77e-05	CbGpPWpGaD
Nicardipine—CHRM3—Signaling Pathways—RAF1—dilated cardiomyopathy	1.1e-05	2.76e-05	CbGpPWpGaD
Nicardipine—CHRM2—Signaling Pathways—RAF1—dilated cardiomyopathy	1.09e-05	2.73e-05	CbGpPWpGaD
Nicardipine—ADRA1A—Signaling Pathways—RAF1—dilated cardiomyopathy	1.09e-05	2.73e-05	CbGpPWpGaD
Nicardipine—CHRM5—Signaling Pathways—EGFR—dilated cardiomyopathy	1.07e-05	2.7e-05	CbGpPWpGaD
Nicardipine—CALM3—Signaling by GPCR—EGFR—dilated cardiomyopathy	1.07e-05	2.68e-05	CbGpPWpGaD
Nicardipine—CALM2—Signaling by GPCR—EGFR—dilated cardiomyopathy	1.03e-05	2.6e-05	CbGpPWpGaD
Nicardipine—CALM1—Signaling by GPCR—EGFR—dilated cardiomyopathy	1.03e-05	2.6e-05	CbGpPWpGaD
Nicardipine—ADRA1D—Signaling Pathways—EGFR—dilated cardiomyopathy	1.01e-05	2.54e-05	CbGpPWpGaD
Nicardipine—CALM3—Immune System—EGFR—dilated cardiomyopathy	9.77e-06	2.45e-05	CbGpPWpGaD
Nicardipine—CALM1—Immune System—EGFR—dilated cardiomyopathy	9.45e-06	2.37e-05	CbGpPWpGaD
Nicardipine—CALM2—Immune System—EGFR—dilated cardiomyopathy	9.45e-06	2.37e-05	CbGpPWpGaD
Nicardipine—CALM3—Signaling Pathways—RAF1—dilated cardiomyopathy	9.21e-06	2.31e-05	CbGpPWpGaD
Nicardipine—CALM3—Disease—EGFR—dilated cardiomyopathy	9.02e-06	2.26e-05	CbGpPWpGaD
Nicardipine—CALM2—Signaling Pathways—RAF1—dilated cardiomyopathy	8.91e-06	2.24e-05	CbGpPWpGaD
Nicardipine—CALM1—Signaling Pathways—RAF1—dilated cardiomyopathy	8.91e-06	2.24e-05	CbGpPWpGaD
Nicardipine—CALM2—Disease—EGFR—dilated cardiomyopathy	8.72e-06	2.19e-05	CbGpPWpGaD
Nicardipine—CALM1—Disease—EGFR—dilated cardiomyopathy	8.72e-06	2.19e-05	CbGpPWpGaD
Nicardipine—CYP3A4—Metabolism—GPX1—dilated cardiomyopathy	8.45e-06	2.12e-05	CbGpPWpGaD
Nicardipine—ADRA1B—Signaling Pathways—EGFR—dilated cardiomyopathy	8.38e-06	2.1e-05	CbGpPWpGaD
Nicardipine—CYP3A4—Metabolism—CD36—dilated cardiomyopathy	8.23e-06	2.07e-05	CbGpPWpGaD
Nicardipine—CHRM1—Signaling Pathways—EGFR—dilated cardiomyopathy	7.57e-06	1.9e-05	CbGpPWpGaD
Nicardipine—CHRM3—Signaling Pathways—EGFR—dilated cardiomyopathy	7.54e-06	1.89e-05	CbGpPWpGaD
Nicardipine—CHRM2—Signaling Pathways—EGFR—dilated cardiomyopathy	7.47e-06	1.87e-05	CbGpPWpGaD
Nicardipine—ADRA1A—Signaling Pathways—EGFR—dilated cardiomyopathy	7.45e-06	1.87e-05	CbGpPWpGaD
Nicardipine—CYP3A4—Metabolism—AGT—dilated cardiomyopathy	7.41e-06	1.86e-05	CbGpPWpGaD
Nicardipine—CALM3—Signaling Pathways—EGFR—dilated cardiomyopathy	6.31e-06	1.59e-05	CbGpPWpGaD
Nicardipine—CALM2—Signaling Pathways—EGFR—dilated cardiomyopathy	6.11e-06	1.53e-05	CbGpPWpGaD
Nicardipine—CALM1—Signaling Pathways—EGFR—dilated cardiomyopathy	6.11e-06	1.53e-05	CbGpPWpGaD
